期刊文献+

异氟烷心肌保护的分子机制的初步研究 被引量:4

Isoflurane induces vascular endothelial growth factor expression via activation of protein kinase C in cardiac myocytes
暂未订购
导出
摘要 目的:探讨异氟烷对心肌细胞血管内皮生长因子(vascular endothelial growth factor,VEGF)直接调节作用的细胞内信号转导途径,进一步揭示异氟烷心肌保护的分子机制。方法:分离培养原代SD大鼠心肌细胞,随机分为4组。对照组(CON组),细胞不经任何处理;异氟烷组(ISO组),细胞经1.4%的异氟烷处理6 h;蛋白激酶C(PKC)抑制剂组(CAL组),细胞经calphostin C 50 nmol.L-1孵育6 h;PKC抑制剂+异氟烷组(IC组),细胞经calphostin C及异氟烷共同作用6 h。对心肌细胞处理结束后采用Elisa法测定细胞培养液VEGF浓度,采用Western blotting法测定心肌细胞PKC亚型的表达。结果:与CON组比较,ISO组VEGF值显著升高(P<0.01);CAL组经PKC抑制剂calphostin C处理后,VEGF含量显著降低,明显低于ISO组(P<0.01);CAL组和CON组比较差异无统计学意义。异氟烷显著诱导PKC-epsilon(PKCε)激活转位,与CON组比较,1.4%的异氟烷组PKCα、PKCδ和PKCζ亚型在细胞质和细胞膜的表达均无统计学差异,但细胞膜PKCε亚型浓度显著升高,而细胞质的浓度显著降低(P<0.01)。结论:异氟烷通过蛋白激酶PKC-epsilon途径诱导心肌细胞分泌VEGF,有可能是异氟烷心肌保护机制之一。 Objective: To investigate the effect of isoflurane on VEGF expression and associated signaling pathway in cultured rat cardiac myocytes.Methods: Primary cultures of rat cardiomyocytes were randomized into the following groups.The control group cells were incubated without any treatment.The isoflurane group cells were treated with isoflurane at 1.4% for 6 hours.The PKC inhibitor group cells were treated with PKC inhibitor calphostin C at a final concentration of 50 nmol·L-1.The PKC inhibitor + isoflurane group cells were treated with 50 nmol·L-1 calphostin C and 1.4% isoflurane for 6 hours.VEGF expressions were identified by enzyme-linked immunosorbent assay and PKC isoforms expressions were determined by Western blotting.Results: The effect of isoflurane on VEGF upregulation was blocked by PKC inhibitor calphostin C,however,calphostin did not alter VEGF expression(P0.05).Isoflurane induced PKCε activation and translocation.Immunoblot analysis revealed that the immunoreactivity for PKCε but not for PKCα,PKCδ and PKCζ increased significantly in the membrane fractions and deceased significantly in the cytosol fractions from cells treated with the 1.4% isoflurane,when compared with non-treatment cells(P0.01).Conclusion: Isoflurane induces VEGF secretion in cardiac myocytes through translocation of PKCε from the cytosol to the cell membrane,suggesting a possible novel mechanism of isoflurane induced cardiac protection.
出处 《东南大学学报(医学版)》 CAS 2011年第5期699-702,共4页 Journal of Southeast University(Medical Science Edition)
基金 湖北省科技攻关计划(2009)(302131741)
关键词 异氟烷 心肌细胞 蛋白激酶C 血管内皮生长因子 大鼠 Sprague-Dawley isoflurane cardiac myocyte protein kinase C vascular endothelial growth factor rats Sprague-Dawley
  • 相关文献

参考文献10

  • 1DARGIE H.Heart failure post-myocardial infarction:a review of the issues[J].Heart,2005,91(Suppl 2):ii3-6.
  • 2KAWATA H,YOSHIDA K,KAWAMOTO A,et al.Ischemic preconditioning upregulates vascular endothelial growth factor mRNA expression and neovascularization via nuclear translocation of protein kinase C epsilon in the rat ischemic myocardium[J].Circ Res,2001,88(7):696-704.
  • 3JAMNICKI-ABEGG M,WEIHRAUCH D,PAGEL P S,et al.Isoflurane inhibits cardiac myocyte apoptosis during oxidative and inflammatory stress by activating Akt and enhancing Bcl-2 expression[J].Anesthsiology,2005,103(5):1006-1014.
  • 4OBAL D,WEBER N C,ZACHAROWSKI K,et al.Role of protein kinase C-epsilon(PKC epsilon) in isoflurane-induced cardioprotection[J].Br J Anaesth,2005,94(2):166-173.
  • 5KANAYA N,GABLE B,MURRAY P A,et al.Propofol increases phosphorylation of troponin I and myosin light chain 2 via protein kinase C activation in cardiomyocytes[J].Anesthesiology,2003,98(6):1363-1371.
  • 6NEUFELD G,COHEN T,GENGRINOVITCH S,et al.Vascular endothelial growth factor(VEGF) and its receptors[J].FASEB J,1999,13(1):9-22.
  • 7UECKER M,da SILVA R,GRAMPP T,et al.Translocation of protein kinase C isoforms to subcellular targets in ischemic and anesthetic preconditioning[J].Anesthesiology,2003,99(1):138-147.
  • 8PRAVDIC D,SEDLIC F,MIO Y,et al.Anesthetic-induced preconditioning delays opening of mitochondrial permeability transition pore via protein kinase C-epsilon-mediated pathway[J].Anesthesiology,2009,111(2):267-274.
  • 9LUDWIG L M,WEIHRAUCH D,KERSTEN J R,et al.Protein kinase C translocation and Src protein tyrosine kinase activation mediate isoflurane-induced preconditioning in vivo:potential downstream targets of mitochondrial adenosine triphosphate-sensitive potassium channels and reactive oxygen species[J].Anesthesiology,2004,100(3):532-539.
  • 10GRUNEWALD M,AVRAHAM I,DOR Y,et al.VEGF-induced adult neovascularization:recruitment,retention,and role of accessory cells[J].Cell,2006,124(1):175-189.

同被引文献57

  • 1杨孟昌,陈玉培,徐茜,曹德钧,张文胜,刘进.乳化异氟醚对缺氧/复氧乳鼠心肌细胞的作用及对caspase-3表达的影响[J].中国全科医学,2009,12(8):625-628. 被引量:4
  • 2程训民,江时森.心血管病新的治疗靶点——线粒体通透转运孔开放[J].医学研究生学报,2011,24(10):103-107. 被引量:3
  • 3李恒,孙凯,杨承祥,孟宪慧.氟烷、异氟醚和恩氟烷对缺血再灌注心肌的保护作用[J].河南医学研究,2005,14(3):230-234. 被引量:3
  • 4Zhou JX,Luo NF,Liang XM. The efficacy and safety of intravenous emulsified isoflurane in rats[J].Anesthesia and Analgesia,2006,(01):129-134.
  • 5Zhao ZQ,Corvera JS,Halkos ME. Inhabition of myocardial injury by ischemic postconditioning during reperfusion:comparision with ischemic preconditioning[J].American Journal of Physiology-Heart and Circulatory Physiology,2003,(02):H579-H588.
  • 6Tsang A,Hausenloy DJ,Mocanu MM. Postconditioning:a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3 kinase-Akt pathway[J].Circulation Research,2004,(03):230-232.
  • 7Kin H,Zhao ZQ,Sun HY. Postconditioning attenuates myocardial ischemia-referfusion injury by inhibiting events in the early minutes of reperfusion[J].Cardiovascular Research,2004,(01):74-85.
  • 8Sedlic F,Sepac A,Pravdic D. Mitochondrial depolarization underlies delay in permeability transition by preconditioning with isoflurane:roles of ROS and Ca2 +[J].American Journal of Physiology-Cell Physiology,2010,(02):C506515.
  • 9Yoshida A,Asanuma H,Sasaki H. H(2) Mediates Cardioprotection Via Involvements of K (ATP) Channels and Permeability Transition Pores of Mitochondria in Dogs[J].Cardiovascular Drugs and Therapy,2012.17.
  • 10Pravdic D,Mio Y,Sedlic F. Isoflurane protects cardiomyocytes and mitochondria by immediate and cytosol-independent action at reperfusion[J].British Journal of Pharmacology,2010,(02):220-232.

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部